Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer

Cancer is one of the leading causes of death from non-infectious diseases in the whole world. Moreover, effective screening and early diagnosis and treatment of cancers have always been a major clinical difficulty. Therefore, it is urgent that novel potential biomarkers or molecular targets are iden...

Full description

Bibliographic Details
Main Author: LI Zhiming , LONG Feng , HE Jianxin , HUANG Yong , SUN Shaokang
Format: Article
Language:English
Published: Editorial Office of China Oncology 2021-04-01
Series:Zhongguo aizheng zazhi
Subjects:
Online Access:http://www.china-oncology.com/fileup/1007-3639/PDF/20210416.pdf
_version_ 1811198040085626880
author LI Zhiming , LONG Feng , HE Jianxin , HUANG Yong , SUN Shaokang
author_facet LI Zhiming , LONG Feng , HE Jianxin , HUANG Yong , SUN Shaokang
author_sort LI Zhiming , LONG Feng , HE Jianxin , HUANG Yong , SUN Shaokang
collection DOAJ
description Cancer is one of the leading causes of death from non-infectious diseases in the whole world. Moreover, effective screening and early diagnosis and treatment of cancers have always been a major clinical difficulty. Therefore, it is urgent that novel potential biomarkers or molecular targets are identified to improve the diagnosis and treatment of cancer patients. In recent years, it has been found that long non-coding RNAs (lncRNAs) are a series of main regulatory factors in biological behaviors and diseases including tumors, and are expected to become novel biomarkers and molecular targets for tumor detection and treatment. Actin filament-associated protein 1-antisense RNA 1 (AFAP1-AS1) was initially identified as a carcinogenic lncRNA in esophageal adenocarcinoma, and later as a carcinogenic regulator of various malignant tumors. The abnormal overexpression of AFAP1-AS1 can regulate the proliferation, apoptosis, invasion and metastasis of tumor cells through different molecular mechanisms. The up- regulation of AFAP1-AS1 in tumor tissues has important clinical significance. Understanding the function and mechanism of this lncRNA in cancers can further help to explore new strategies for the prevention and treatment of malignant tumors. Therefore, this paper reviewed the effects, relevant molecular mechanisms and potential clinical significance of AFAP1-AS1 in multiple human malignant tumors, so as to provide a scientific theoretical basis for its early clinical application.
first_indexed 2024-04-12T01:24:17Z
format Article
id doaj.art-8c87363ad0bf4c7e967ee510975b96e5
institution Directory Open Access Journal
issn 1007-3639
language English
last_indexed 2024-04-12T01:24:17Z
publishDate 2021-04-01
publisher Editorial Office of China Oncology
record_format Article
series Zhongguo aizheng zazhi
spelling doaj.art-8c87363ad0bf4c7e967ee510975b96e52022-12-22T03:53:42ZengEditorial Office of China OncologyZhongguo aizheng zazhi1007-36392021-04-0131435036010.19401/j.cnki.1007-3639.2021.04.016Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancerLI Zhiming , LONG Feng , HE Jianxin , HUANG Yong , SUN Shaokang01. Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China; 2. Provincial-Level Key Laboratory for Molecular Medicine of Major Disease and Treatment with Traditional Chinese Medicine Research in Gansu Colleges and Universities, Lanzhou 730000, Gansu Province, ChinaCancer is one of the leading causes of death from non-infectious diseases in the whole world. Moreover, effective screening and early diagnosis and treatment of cancers have always been a major clinical difficulty. Therefore, it is urgent that novel potential biomarkers or molecular targets are identified to improve the diagnosis and treatment of cancer patients. In recent years, it has been found that long non-coding RNAs (lncRNAs) are a series of main regulatory factors in biological behaviors and diseases including tumors, and are expected to become novel biomarkers and molecular targets for tumor detection and treatment. Actin filament-associated protein 1-antisense RNA 1 (AFAP1-AS1) was initially identified as a carcinogenic lncRNA in esophageal adenocarcinoma, and later as a carcinogenic regulator of various malignant tumors. The abnormal overexpression of AFAP1-AS1 can regulate the proliferation, apoptosis, invasion and metastasis of tumor cells through different molecular mechanisms. The up- regulation of AFAP1-AS1 in tumor tissues has important clinical significance. Understanding the function and mechanism of this lncRNA in cancers can further help to explore new strategies for the prevention and treatment of malignant tumors. Therefore, this paper reviewed the effects, relevant molecular mechanisms and potential clinical significance of AFAP1-AS1 in multiple human malignant tumors, so as to provide a scientific theoretical basis for its early clinical application.http://www.china-oncology.com/fileup/1007-3639/PDF/20210416.pdflncrna|afap1-as1|cancer|mechanism
spellingShingle LI Zhiming , LONG Feng , HE Jianxin , HUANG Yong , SUN Shaokang
Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer
Zhongguo aizheng zazhi
lncrna|afap1-as1|cancer|mechanism
title Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer
title_full Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer
title_fullStr Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer
title_full_unstemmed Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer
title_short Research progress on the mechanism of long chain non-coding RNA AFAP1-AS1 in cancer
title_sort research progress on the mechanism of long chain non coding rna afap1 as1 in cancer
topic lncrna|afap1-as1|cancer|mechanism
url http://www.china-oncology.com/fileup/1007-3639/PDF/20210416.pdf
work_keys_str_mv AT lizhiminglongfenghejianxinhuangyongsunshaokang researchprogressonthemechanismoflongchainnoncodingrnaafap1as1incancer